Status:
UNKNOWN
The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The gastric cancer is the second most frequently diagnosed cancer and the third leading cause of cancer death in China.80%-90% patients were detected at middle and later stage.The five-year survival r...
Detailed Description
The gastric cancer is the second most frequently diagnosed cancer and the third leading cause of cancer death in China.80%-90% patients were detected at middle and later stage.The five-year survival r...
Eligibility Criteria
Inclusion
- Age：18-70
- Sex：unlimited；
- Group 1：patients with EGC，willing to receive treatment under endoscopy（EMR/ESD）
- Group 2：patients for screening，or have some general symptoms dyspepsia、epigastric pain）who need to be examined by endoscopy
- Informed consent issued
Exclusion
- Severe liver and kidney disease;
- Iodine, seafood or other severe allergies history；
- Patients with severe heart or pulmonary disease which is not suitable for endoscopic examination
- Higher blood risk of esophageal varices
- Pregnant or lactating female
- Without patient's consent
- The investigator considers other condition which is not suitable for participation
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02710838
Start Date
January 1 2014
End Date
February 1 2017
Last Update
March 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, China, 710032